Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Viyash Scientific's share price for the quarter that ended in Mar. 2026 was ₹182.82. Viyash Scientific's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 436 Mil. Therefore, Viyash Scientific's market cap for the quarter that ended in Mar. 2026 was ₹79,790 Mil.
Viyash Scientific's quarterly market cap
increased
from Sep. 2025 (₹46,803 Mil) to Dec. 2025 (₹90,865 Mil) but then
declined
from Dec. 2025 (₹90,865 Mil) to Mar. 2026 (₹79,790 Mil).
Viyash Scientific's annual market cap
increased
from Mar. 2024 (₹28,762 Mil) to Mar. 2025 (₹32,691 Mil) and
increased
from Mar. 2025 (₹32,691 Mil) to Mar. 2026 (₹79,790 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Viyash Scientific's Enterprise Value for Today is ₹121,953 Mil.
Viyash Scientific (NSE:VIYASH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Viyash Scientific Market Cap Related Terms
Viyash Scientific Market Cap Historical Data
* Premium members only.
The historical data trend for Viyash Scientific's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Viyash Scientific's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viyash Scientific Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Viyash Scientific's Market Cap distribution charts can be found below:
* The bar in red indicates where Viyash Scientific's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Viyash Scientific's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viyash Scientific (NSE:VIYASH) has a Market Cap of ₹117,736 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Viyash Scientific and its competitors. According to the industry distribution chart, Viyash Scientific ranks #220 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 21.6%.
Is Viyash Scientific's Market Cap too high?
Viyash Scientific's current Market Cap is ₹117,736 Mil. Based on the distribution chart, Viyash Scientific ranks #220 out of 1020 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Viyash Scientific has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viyash Scientific's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Viyash Scientific ranks #220 out of 1020 companies for Market Cap. This places Viyash Scientific in the top 22% of its industry — outperforming the majority of peers. The industry median Market Cap is 213.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.67, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Viyash Scientific and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viyash Scientific's current Market Cap is ₹117,736 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viyash Scientific stock overvalued right now?
Based on GuruFocus' analysis, Viyash Scientific (NSE:VIYASH) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹171.86, compared to a current price of ₹269.80 — trading 57% above its estimated fair value. The current Market Cap is ₹117,736 Mil. Viyash Scientific's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Viyash Scientific (NSE:VIYASH), the current Market Cap is ₹117,736 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viyash Scientific (NSE:VIYASH) Overvalued in 2026?
Based on GuruFocus' analysis, Viyash Scientific stock appears to be overvalued.
The current stock price of ₹269.80 is trading 57% above its estimated GF Value™ of ₹171.86.
GuruFocus considers Viyash Scientific to be Significantly Overvalued.
Key valuation signals for NSE:VIYASH:
Market Cap: ₹117,736 Mil
GF Value™: ₹171.86 vs. price of ₹269.80 (57% above fair value)
No single metric tells the full story. See the NSE:VIYASH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viyash Scientific Ltd is a pharmaceutical company with activities spanning formulations, active pharmaceutical ingredients (APIs), and intermediates. It is focused on research and development infrastructure for APIs and formulations. Its product portfolio spans several therapeutic areas, including ARV, cardiovascular, central nervous system, analgesics, antibiotics, antihistamines, diabetes, gastrointestinal, anticoagulants, and oncology.
72GF Score
Get the complete analysis for NSE:VIYASH
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VIYASH has been successfully added to your 
